Seeking to inform development of drugs effective against multiple pathogenic human coronaviruses, the authors compared host interactions of MERS-CoV, SARS-CoV-1 and SARS-CoV-2, uncovering host pathways commonly hijacked by all three. Studying patient data showed how COVID-19 patients treated with drugs that acted against selected coronavirus host factors fared, with results that will help guide COVID-19 drug targets, the authors say.
SARS-CoV-2, which causes COVID-19, is closely related to the deadly coronaviruses SARS-CoV-1 and MERS-CoV. Significant efforts are focused on developing treatments for COVID-19 but given that other highly virulent human coronavirus strains have emerged and may do so again, therapies that work across coronaviruses would also be valuable. While traditional antivirals target viral enzymes that are often subject to mutation, and thus to the development of drug resistance, targeting the host proteins required for viral replication is a strategy that can avoid resistance and lead to therapeutics with broad-spectrum activity.
Focused on this approach, the authors mapped the interactions between viral and human proteins for SARS-CoV-2, SARS-CoV-1 and MERS-CoV. After expressing viral proteins in human cells, they used mass spectrometry to identify human host proteins that physically associated with each viral protein, looking for conserved interactions across all three viruses. They then used genetic screening to identify host factors that either enhanced or inhibited viral infection. To connect their in vitro molecular data to clinical information for COVID-19 patients, the authors evaluated medical billing data on nearly 740,000 patients in the United States with documented SARS-CoV-2 infection.
In this cohort, they studied the use of drugs against selected targets identified in their study, asking whether patients who received them fared better than controls treated with clinically similar drugs that do not act on coronavirus host factors. Patients that received drugs focused against certain selected targets fared better in some cases, the authors report. "Replication in other patient cohorts and further work will be needed to see if there is therapeutic value in these connections," say the authors "but at the very least we have demonstrated a strategy wherein protein network analyses can be used to make testable predictions from real-world, clinical information."
https://science.sciencemag.org/content/early/2020/10/14/science.abe9403
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fcomparative-host&filter=22
Evaluation of three coronavirus interactions with host targets
- 1,122 views
- Added
Edited
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
Mitochondrial Complex I Activity Is Required for Maximal Autophagy
Read more
Novel imaging biomarker to help predict coronary inflammation
Read more
Regrowing and rewiring the spinal cord after injury!
Read more
Depression may raise risk of heart attack and stroke
Read more
EXP2 protein helps malaria parasite obtain nutrients during infection
Researchers have deciphered the role of a key protein that the malaria parasite Plasmodium falciparum uses to obtain nutrients while infecting red blood cells. Their study appears in Nature Microbiology.
According to the World Health Organization, in 2016 there were an estimated 216 million malaria cases and 445,000 malaria deaths. P. falciparum is responsible for most malaria-related deaths…
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar